Región Metropolitana de Santiago
Este organismo compró $13.486.726.006.527 en 34.361 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Glaxosmithkline Chile Farmaceutica Limitada.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $951,1 mil M |
| 2025 | $1,7 B |
| 2024 | $1,8 B |
| 2023 | $1,4 B |
| 2022 | $1,1 B |
| 2021 | $1,2 B |
| 2020 | $1,2 B |
| 2019 | $733,5 mil M |
| 2018 | $526,8 mil M |
| 2017 | $476,6 mil M |
| 2016 | $386,6 mil M |
| 2015 | $399,9 mil M |
| 2014 | $267 mil M |
| 2013 | $274,4 mil M |
| 2012 | $223,1 mil M |
| 2011 | $213,6 mil M |
| 2010 | $190,8 mil M |
| 2009 | $204,7 mil M |
| 2008 | $166,3 mil M |
| 2007 | $196,4 mil M |
| 2006 | $27 mil M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2268-82-AG26 | 11-05-2026 | Importadora y Comercializadora Ugarit Limitada | Aceptada | $4.199.986 |
| 621-437-SE26 | 11-05-2026 | Neoethicals Chile SpA | Aceptada | $105.833.554 |
| 621-449-SE26 | 11-05-2026 | Novofarma Service S.A. | Aceptada | $180.070.800 |
| 621-388-SE26 | 11-05-2026 | Synthon Chile Limitada | Aceptada | $2.013.504.847 |
| 621-420-SE26 | 11-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $442.579.219 |
| 621-524-SE26 | 11-05-2026 | Simil Express S.A. | Aceptada | $153.558.195 |
| 621-399-SE26 | 11-05-2026 | Abbvie Productos Farmaceuticos Limitada | Aceptada | $1.475.417.922 |
| 621-477-TD26 | 08-05-2026 | Grifols Chile S.A. | Aceptada | $2.646.381.500 |
| 621-518-TD26 | 08-05-2026 | Clinical Market S.A. | Aceptada | $52.068.807 |
| 2268-80-AG26 | 08-05-2026 | Servicios Juan Rene Navarrete Valeria EIRL | Aceptada | $672.839 |
| 621-519-TD26 | 08-05-2026 | Novo Nordisk Farmaceutica Limitada | Aceptada | $576.287.250 |
| 621-246-SE26 | 08-05-2026 | Aaflex Bodegas SpA | Aceptada | $950.937.925 |
| 621-379-SE26 | 07-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $453.418.096 |
| 621-382-SE26 | 07-05-2026 | Inversiones Sb S.A. | Aceptada | $1.004.402.186 |
| 621-421-SE26 | 07-05-2026 | Trade Foods & Nutrients SpA | Aceptada | $314.726.630 |
| 621-395-SE26 | 07-05-2026 | Laboratorio Pasteur S.A. | Aceptada | $381.932.832 |
| 621-458-SE26 | 07-05-2026 | Blau Farmaceutica Chile SpA | En proceso | $101.096.982 |
| 621-461-SE26 | 07-05-2026 | Marmedical SpA | Aceptada | $343.062.720 |
| 621-383-SE26 | 07-05-2026 | Alembic Pharmaceuticals SpA | Aceptada | $596.257.652 |
| 2268-69-SE26 | 07-05-2026 | Novofarma Service S.A. | Aceptada | $14.548.583 |
| 2268-74-SE26 | 07-05-2026 | Jomala Inversiones SpA | Aceptada | $21.705.600 |
| 621-304-SE26 | 07-05-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $3.617.491.133 |
| 621-515-SE26 | 07-05-2026 | Ascend Laboratories SpA | Aceptada | $337.228.983 |
| 621-308-SE26 | 07-05-2026 | Laboratorio Flex Pharma Chile Limitada | Aceptada | $580.952.193 |
| 621-397-SE26 | 07-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $1.398.748.484 |
| 621-401-SE26 | 07-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $979.463.558 |
| 621-429-SE26 | 07-05-2026 | Recetario Magistral Endovenoso S.A. | Aceptada | $113.741.271 |
| 621-380-SE26 | 07-05-2026 | Simil Express S.A. | Aceptada | $509.563.950 |
| 621-391-SE26 | 07-05-2026 | Inyecta Laboratorios SpA | Aceptada | $667.873.458 |
| 621-204-TD26 | 06-05-2026 | Laboratorios Wyeth Llc | Enviada a proveedor | $15.092.924.819 |
